REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Octapharma Poland Sp. z o.o. (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Pharmaceutical Preparation Manufacturing | Wholesale Trade Agents and Brokers | Pharmacies and Drug Stores | Department Stores | Other Miscellaneous Store Retailers | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | All Other Support Services | Other Personal and Household Goods Repair and Maintenance
Full name: Octapharma Poland Sp. z o.o. Profile Updated: October 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Octapharma is a global healthcare company. It is one of the largest human protein product manufacturers, with a focus on haematology, immunotherapy, and critical care. The company develops and produces medicines based on human proteins from human cell lines and human plasma, sourced from its own plasma donation centres and other external sources. Octapharma's products are available in 118 countries and reach hundreds of thousands of patients every year. The company operates seven R&D sites and five manufacturing facilities in Austria, France, Germany, and Sweden.

Headquarters
Ul. Jana Karola Chodkiewicza 8/U12
Warsaw; Mazowieckie; Postal Code: 02-593

Contact Details: Purchase the Octapharma Poland Sp. z o.o. report to view the information.

Website: http://www.octapharma.com

Basic Information
Total Employees:
Purchase the Octapharma Poland Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Octapharma Poland Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Octapharma Poland Sp. z o.o. report to view the information.
Incorporation Date:
November 19, 2012
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Octapharma Poland Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
15.41%▲
Total operating revenue
15.37%▲
Operating profit (EBIT)
15.16%▲
Net Profit (Loss) for the Period
15.91%▲
Total assets
8.96%▲
Total equity
6.71%▲
Operating Profit Margin (ROS)
-0.01%▼
Net Profit Margin
0.02%▲
Return on Equity (ROE)
0.5%▲
Quick Ratio
-1.19%▼
Cash Ratio
-0.79%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo